Opinion · 29 Oct 2025
Conference proceedingPublished Aug 2020
Human Leukocyte Antigen G as a Novel Target for Switch-based Chimeric Antigen Receptor Natural Killer Cell Therapy of Solid Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Challenges present with chimeric antigen receptors (CARs) adoptive cell therapy against solid tumors have been lacking a ubiquitous tumor-associated antigen across different tumor types, tumor antigen expression heterogeneity, and the immunosuppressive nonphysical tumor microenvironment. Thus, we developed a switch anti human leukocyte antigen (HLA)-G CAR that binds to HLA-G1~G7
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Inflammation, Cancer and Integrative Therapy.
Short communication · 29 Oct 2025
Systems Biology: From Description to Prediction and Engineering
Editorial · 29 Oct 2025
Cancer Cachexia: Management, Mechanisms, and Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Inflammation, Cancer and Integrative Therapy
- SubjectImmunology & Microbiology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “peter D Canoll”